These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 29245249)

  • 1. Characteristics of culture-positive invasive pulmonary aspergillosis in patients with hematologic diseases: Comparison between Aspergillus fumigatus and non-fumigatus Aspergillus species.
    Cho SY; Lee DG; Choi JK; Lee HJ; Kim SH; Park SH; Choi SM; Choi JH; Yoo JH; Park YJ; Lee JW
    Medicine (Baltimore); 2017 Dec; 96(49):e8841. PubMed ID: 29245249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of serum galactomannan, (1,3)-β-d-glucan, and Aspergillus fumigatus-specific IgA and IgG assays for invasive pulmonary aspergillosis in non-neutropenic patients.
    Dobias R; Jaworska P; Tomaskova H; Kanova M; Lyskova P; Vrba Z; Holub C; Svobodová L; Hamal P; Raska M
    Mycoses; 2018 Aug; 61(8):576-586. PubMed ID: 29575150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
    Nguyen MH; Leather H; Clancy CJ; Cline C; Jantz MA; Kulkarni V; Wheat LJ; Wingard JR
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1043-50. PubMed ID: 21087680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics, radiologic findings, risk factors and outcomes of serum galactomannan-negative invasive pulmonary aspergillosis.
    Jung J; Kim MY; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    J Microbiol Immunol Infect; 2018 Dec; 51(6):802-809. PubMed ID: 28712819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory invasive pulmonary aspergillosis due to Aspergillus flavus detected with the combination of two in-house Aspergillus qPCR.
    Caillet A; Bellanger AP; Navellou JC; Daguindau E; Rocchi S; Scherer E; Berceanu A; Millon L
    J Mycol Med; 2023 Mar; 33(1):101350. PubMed ID: 36375310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Aspergillus fumigatus real-time PCR in bronchoalveolar lavage samples (BAL) for diagnosis of invasive aspergillosis, including azole-resistant cases, in high risk haematology patients: the need for a combined use with galactomannan.
    Mikulska M; Furfaro E; De Carolis E; Drago E; Pulzato I; Borghesi ML; Zappulo E; Raiola AM; Grazia CD; Del Bono V; Cittadini G; Angelucci E; Sanguinetti M; Viscoli C
    Med Mycol; 2019 Nov; 57(8):987-996. PubMed ID: 30753590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosing Invasive Pulmonary Aspergillosis in Hematology Patients: a Retrospective Multicenter Evaluation of a Novel Lateral Flow Device.
    Mercier T; Schauwvlieghe A; de Kort E; Dunbar A; Reynders M; Guldentops E; Rijnders B; Verweij PE; Lagrou K; Maertens J
    J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30651395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Two Commercial Real-Time PCR Kits for Aspergillus DNA Detection in Bronchoalveolar Lavage Fluid in Patients with Invasive Pulmonary Aspergillosis.
    Denis J; Forouzanfar F; Herbrecht R; Toussaint E; Kessler R; Sabou M; Candolfi E; Letsher-Bru V
    J Mol Diagn; 2018 May; 20(3):298-306. PubMed ID: 29471112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case Series Study of Invasive Pulmonary Aspergillosis.
    Aller-García AI; Castro-Méndez C; Alastruey-Izquierdo A; Marín-Martínez EM; Breval IZ; Couto-Caro C; López-Marín JC; Peña-Griñán N; Ruiz de Pipaon M; Romero-Mejías AM; Martín-Mazuelos E
    Mycopathologia; 2017 Jun; 182(5-6):505-515. PubMed ID: 27913978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of galactomannan antigen test in serum and bronchoalveolar lavage fluid sample from suspected patients of invasive pulmonary aspergillosis.
    Malhotra S; Kumari R; Chauhan AK; Bhatia NK; Kaur A; Sharma B; Duggal N
    Indian J Pathol Microbiol; 2021; 64(4):732-734. PubMed ID: 34673593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive pulmonary aspergillosis in non-neutropenic patients: analysis of a 14-month prospective clinical experience.
    Russo A; Falcone M; Vena A; Venditti C; Mancini C; Morelli A; Venditti M
    J Chemother; 2011 Oct; 23(5):290-4. PubMed ID: 22005062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive pulmonary aspergillosis is associated with adverse clinical outcomes in critically ill patients receiving veno-venous extracorporeal membrane oxygenation.
    Rodriguez-Goncer I; Thomas S; Foden P; Richardson MD; Ashworth A; Barker J; Geraghty CG; Muldoon EG; Felton TW
    Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1251-1257. PubMed ID: 29623451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of mycological, nested PCR, and real-time PCR methods on BAL fluids for detection of Aspergillus fumigatus and A. flavus in solid organ transplant recipients.
    Zarrinfar H; Mirhendi H; Makimura K; Satoh K; Khodadadi H; Paknejad O
    Mycopathologia; 2013 Dec; 176(5-6):377-85. PubMed ID: 24045934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of sputum Aspergillus galactomannan for diagnosis of invasive pulmonary aspergillosis in haematological patients.
    Kimura SI; Odawara J; Aoki T; Yamakura M; Takeuchi M; Matsue K
    Int J Hematol; 2009 Nov; 90(4):463-470. PubMed ID: 19838867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential value of serum Aspergillus IgG antibody detection in the diagnosis of invasive and chronic pulmonary aspergillosis in non-agranulocytic patients.
    Yu Q; He J; Xing B; Li X; Qian H; Zhang H; Xu M; Peng H
    BMC Pulm Med; 2020 Apr; 20(1):89. PubMed ID: 32293386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a novel inhalational model of invasive pulmonary aspergillosis in rats and comparative evaluation of three biomarkers for its diagnosis.
    Ahmad S; Al-Shaikh AA; Khan Z
    PLoS One; 2014; 9(6):e100524. PubMed ID: 24955575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Aspergillus-specific IgE, IgG and IgG4 immunoglobulins assessment in the work-up of invasive pulmonary aspergillosis: a prospective cohort study.
    Tirelli C; DE Amici M; Piloni D; Sacchi L; Mariani F; Testa G; Torre C; Ciprandi G; Centanni S; Marseglia G; Corsico AG
    Minerva Med; 2023 Aug; 114(4):433-443. PubMed ID: 35904372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19-associated pulmonary aspergillosis (CAPA): identification of Aspergillus species and determination of antifungal susceptibility profiles.
    Ozturk A; Bozok T; Erdogan M; Ibrahim BM; Bozok TS
    Folia Microbiol (Praha); 2023 Dec; 68(6):951-959. PubMed ID: 37294497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of involved Aspergillus species on galactomannan in bronchoalveolar lavage of patients with invasive aspergillosis.
    Taghizadeh-Armaki M; Hedayati MT; Moqarabzadeh V; Ansari S; Mahdavi Omran S; Zarrinfar H; Saber S; Verweij PE; Denning DW; Seyedmousavi S
    J Med Microbiol; 2017 Jul; 66(7):898-904. PubMed ID: 28693685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline serum Aspergillus galactomannan index in patients with hematologic malignancy and culture-documented invasive pulmonary aspergillosis: is there a difference among Aspergillus species?
    Magira EE; Jiang Y; Kontoyiannis DP
    Med Mycol; 2019 Jul; 57(5):639-642. PubMed ID: 30339235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.